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Angiomyolipoma is a benign neoplasm composed of varying admixtures of blood vessels, smooth muscle cells, and adipose tissue.
Because of an increased risk of spontaneous haemorrhage, surgical approach is needed greater than 4–8cm size. We here report
our partial nephrectomy experience in the 24cm size giant angiomyolipoma. 26-year-old woman referred to our clinic with a
24cm size angiomyolipoma in her lower pole of right kidney. The inferior vena cava was deviated to the left by the mass. All the
blood tests were normal and we oﬀered her the choices of partial nephrectomy or nephrectomy. Right subcostal approach was
used. The patient underwent resection of the mass with a safety region of 1cm. Frozen section evaluation was consistent with
angiomyolipoma and free for surgical margin. Warm ischemia time was 35min. and intraoperative bleeding volume was 200cc.
Postoperative 2nd day the drain was taken and hospital stay was 4 days. In literature we observed very rare angiomyolipoma
cases with such a large dimension treated by partial nephrectomy without arterial embolization. If technically suitable partial
nephrectomy is the main chioce in this kind of benign lesions in young patients.
1.Introduction
Angiomyolipoma (AML)isararebenignneoplasm, typically
composed of varying admixtures of blood vessels, smooth
muscle cells, and adipose tissue (1). The average size of these
tumors is 2 to 8cm, with cases involving tumors of up to
20cm reported in literature [1, 2].
Because of an increased risk of spontaneous haemor-
rhage, selective transcatheter arterial embolization (TAE) or
surgical approach are needed greater than 4 to 8cm size. We
here report our partial nephrectomy experience in the 24cm
size giant angiomyolipoma.
2.CaseReport
A 26-year-old woman without the tuberous sclerosis com-
plex (TSC) presented with abdominal fullness, right upper
quadrant pain and constipation. On physical examination,
a right upper quadrant mass was palpated bimanually.
Computerized tomography of abdomen demonstrated a
24cm size angiomyolipoma that was arising from the lower
pole of the right kidney (Figure 1). The inferior vena cava
was deviated to the left by the mass. All the blood tests
were normal and we oﬀered her the choices of partial
nephrectomy or nephrectomy. Right subcostal approach was
used. After peritoneal incision the mesocolon was reﬂected
medially along the line of Toldt. Clear uninvolved plane was
foundbetweenthemassandthevenacavaanddissected.The
renal artery and vein were occluded with a bulldog clamp.
The patient underwent resection of the mass with a safety
regionof1cm.Frozensectionevaluationwasconsistentwith
angiomyolipoma and free of surgical margin. The collecting
system and renal defect were closed (Figure 2).2 Case Reports in Medicine
Figure 1: MRI showing a right retroperitoneal mass.
Figure 2: Intraoperative view of the AML.
Histopathology showed an encapsulated soft tissue mass
which was measured 24cm at its greatest dimension and
weighed 3425g. The lesion was characterized microscopi-
cally by a proliferation of cells, including those demonstrat-
ing adipose and smooth muscle diﬀerentiation, with the
formation of thick-walled vascular structures (Figure 3).
Warm ischemia time was 35min and intraoperative
bleeding volume was 200cc. The patient’s postoperative
course was uneventful. Postoperative 2nd day the drain was
taken and she was discharged home on postoperative day 4.6
months later we evaluated the right kidney as a normal one
except postoperative diﬀerences (Figure 4).
3. Discussion
Renal AML is a benign mesenchymal tumor, identiﬁed in
less than 0.2% of the general population and a prevalence of
0.3% to 3% of all surgical resected renal tumors [1]. Twenty
percent of these tumors are seen in patients with TSC and
majority of patients with TSC (80%) develop AMLs [3].
Some authors have recommended intensive intervention for
patients with these tumors and others have reported that all
ofthesetumorsdonotnecessarilyrequireintervention[4,5].
In general asymptomatic AMLs with a diameter of
4cm or smaller can be followed by imaging studies. Active
surveillance can be performed even for large AMLs which
Figure 3: Microscopic view of the mass.
Figure 4: MRI of the right kidney, 6 months after the operation.
do not uniformly become symptomatic until reaching more
than 8cm [6]. For larger tumors, particularly if the patient
is symptomatic, surgical intervention should be considered.
A nephron-sparing approach, via partial nephrectomy or
TAE, is preferred in patients with small AMLs requiring
intervention because of symptoms, in patients with tuberous
sclerosis or multicentric AMLs, and in patients whom
preservation of renal function is important.
TAE is a safe and tolerable procedure it can be done to
decrease the risk of bleeding without loss of renal function.
After TAE, the recuurence is infrequent but additional
treatment may be necessary [7, 8]. The risk of unexpected
large ischemic changes should be kept in mind [6]. Lifelong
surveillance for recurrance is essential after AML emboliza-
tion [7, 8].
Recently several cases have been reported for whom
nephron-sparing surgery was performed. Especially in spo-
radic renal AML, this technique oﬀers preservation of
renal function with acceptable complication and recurrence
rates. Preoperative embolization of the large tumors is
recommended to avoid excess blood loss during surgery [9].
But the reduction in tumour volume is only modest (28%)
[10].
In our case report we performed a partial nephrectomy
procedure in a young female patient without tuberousCase Reports in Medicine 3
sclerosis complex. We met very rare AML cases with such big
dimensionsthatweretreatedbypartialnephrectomywithout
arterial embolization in our literature survey.
Patient’s age, strong diabetes history in her family, the
anatomical localisation of the tumor in the kidney with the
adjacent organs were the main reasons for the decision of
the nephron-sparing surgery. We did not try preoperative
embolization because of its modest eﬀect on tumor size and
to avoid additional burden for our patient. Although our
intraoperative bleeding volume was acceptable, we believe
that preoperative embolization may reduce this risk.
The management of AML is a complex procedure espe-
cially in large or multiple ones. TAE is eﬀective at controlling
acute haemorhage but has limited value in the long term
management. It may help us before surgical intervention
to prevent hemorrhage. New treatment modalities such as
focused ablation and the use of antiangiogenic molecules
should be further explored. Although life-threatening hem-
orrhage or ﬁstulas of the collecting system are the main
complications partial nephrectomy may be the best choice
if the patient’s anatomy is available and your surgical
experience is enough about nephron-sparing surgery.
Discloure
The authors have no relevant academic and ﬁnancial disclo-
sures or conﬂicts of interests and have listed their outside
activities separately. All authors meet authorship criteria
and participated fully in the write-up and submission of
the manuscript. The authors attest that this manuscript is
an original work with no prior publication of manuscript
contents and is not under consideration for publication
elsewhere.
References
[1] C. P. Nelson and M. G. Sanda, “Contemporary diagnosis and
management of renal angiomyolipoma,” Journal of Urology,
vol. 168, pp. 1315–1325, 2002.
[ 2 ]J .E .O e s t e r l i n g ,E .K .F i s h m a n ,S .M .G o l d m a n ,a n dF .F .
Marshall, “The management of renal angiomyolipoma,” Jour-
nal of Urology, vol. 135, no. 6, pp. 1121–1124, 1986.
[3] W. J. Earthman, M. J. Mazer, and A. C. Winﬁeld, “Angiomy-
olipomas in tuberous sclerosis: subselective embolotherapy
with alcohol, with long-term follow-up study,” Radiology, vol.
160, no. 2, pp. 437–441, 1986.
[4] M. S. Steiner, S. M. Goldman, E. K. Fishman, and F. F.
Marshall, “The natural history of renal angiomyolipoma,”
Journal of Urology, vol. 150, no. 6, pp. 1782–1786, 1993.
[5] J. G. van Baal, N. J. Smiths, J. N. Keman, D. Lindhout, and
S. Verhoef, “The evaluation of renal angiomyolipomas in
patients with tuberous sclerosis,” Journal of Urology, vol. 152,
no. 1, pp. 35–38, 1994.
[6] M. Dickinson, H. Ruckle, M. Beaghler, and H. R. Hadley,
“Renal angiomyolipoma: optimal treatment based on size and
symptoms,” Clinical Nephrology, vol. 49, no. 5, pp. 281–286,
1998.
[7] N. Kothary, M. C. Soulen, T. W. I. Clark et al., “Renal
angiomyolipoma: long-term results after arterial emboliza-
tion,” Journal of Vascular and Interventional Radiology, vol. 16,
no. 1, pp. 45–50, 2005.
[ 8 ]V .L .B i s h a y ,P .B .C r i n o ,A .J .W e i ne ta l . ,“ E m b o l i z a t i o no f
giant renal angiomyolipomas: technique and results,” Journal
of Vascular and Interventional Radiology, vol. 21, no. 1, pp. 67–
72, 2010.
[9] A. Singla, S. K. Chaitanya Arudra, and N. Bharti, “Giant
sporadic renal angiomyolipoma treated with nephron-sparing
surgery,” Urology, vol. 74, no. 2, pp. 294–295, 2009.
[10] P. Sooriakumaran, P. Gibbs, G. Coughlin et al., “Angiomy-
olipomata: challenges, solutions, and future prospects based
on over 100 cases treated,” British Journal of Urology Interna-
tional, vol. 105, no. 1, pp. 101–106, 2010.